Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Myocarditis Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

13 recruiting trials for Myocarditis. Eligibility criteria explained in plain English.

TrialFinderData lists 13 Myocarditis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 4 (2 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by Second Affiliated Hospital, School of Medicine, Zhejiang University (2), Scientific Institute San Raffaele (2), Johann Wolfgang Goethe University Hospital (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Endocardiomyocardial biopsy (procedure, 1 trial), followed by Cardiac Imaging, Magnetic Resonance Imaging with Contrast.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
13
Total Trials
13
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Track Myocarditis trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 4NCT05718128

Clinical Study of Endocardial Myocardial Biopsy

In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special...

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 1001 location
RECRUITINGNCT04444128

IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

Magnetic properties of myocardial tissue change in the presence of disease. This is detectable in the change of rate of magnetic relaxation, and measurable by T1 and T2 mapping...

Sponsor: Johann Wolfgang Goethe University HospitalEnrolling: 60001 location
RECRUITINGNCT07354646

The Application of T1 Mapping in Real-World

The goal of this observational study is to create a comprehensive real-world spectrum of T1 mapping measurements across different heart conditions. We aim to establish reference...

Sponsor: Chinese Academy of Medical Sciences, Fuwai HospitalEnrolling: 20001 location
RECRUITINGNCT06730607

Image-Based Prediction of Ventricular Tachycardias in Post-Myocarditis Patients: an International Multicenter...

Ventricular arrhythmias (VAs) are frequently associated with structural heart diseases (SHD) such as myocardial infarction, myocarditis, and non-ischemic cardiomyopathies....

Sponsor: Centro Medico TeknonEnrolling: 1503 locations
RECRUITINGNCT04612296

The Heart Hive - Cardiomyopathy Study

This is an online registry and database of patients with cardiomyopathy and myocarditis, coupled with an observational study of cardiomyopathies.

Sponsor: Imperial College LondonEnrolling: 100001 location
RECRUITINGNCT06889662

GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis.

This study aims to answer multiple unsolved questions in the field of arrhythmic myocarditis. * Improving the diagnostic work-up. While endomyocardial biopsy (EMB) and cardiac...

Sponsor: Scientific Institute San RaffaeleEnrolling: 2621 location
RECRUITINGNCT07617844

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

This single-center, prospective, observational cohort study aims to evaluate the clinical application value of multi-modal cardiovascular magnetic resonance (CMR) imaging in...

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 20001 location
RECRUITINGPhase 4NCT04654988

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

Myocarditis can result in numerous complications, but there is paucity of data regarding optimal therapy, short- and long-term effects of possibly effective immunosuppressive...

Sponsor: Medical University of WarsawEnrolling: 1001 location
RECRUITINGNCT04521790

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic...

Myocarditis is a complex inflammatory disease, usually occurring secondary to viral infections, autoimmune processes or toxic agents. Clinical presentations are multiple,...

Sponsor: Scientific Institute San RaffaeleEnrolling: 10001 location
RECRUITINGNCT06060548

Role of Novel ILR in the Management of PVCs

This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions...

Sponsor: Kansas City Heart Rhythm Research FoundationEnrolling: 506 locations
RECRUITINGNCT03049254

Mayo AVC Registry and Biobank

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest...

Sponsor: Mayo ClinicEnrolling: 10002 locations
RECRUITINGNCT06409585

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition

Heart scarring, also known as fibrosis, plays a major role in a lot of heart muscle abnormalities. These abnormalities of the heart muscle can lead to major issues such as...

Sponsor: University of EdinburghEnrolling: 2901 location
RECRUITINGNCT07077304

EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases

Inflammatory Cardiovascular Diseases and Autoimmune Rheumatic Diseases (ICARDs) encompass cardiovascular involvement in connective tissue diseases, vasculitis, and primary...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 50001 location

Frequently Asked Questions

There are currently 13 clinical trials for Myocarditis, with 13 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Myocarditis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Myocarditis, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.